Press Releases

Hogan Lovells advises Novartis in respiratory cell therapy licensing deal with Mesoblast

Washington, D.C., 23 November 2020 – Global law firm Hogan Lovells has advised international pharmaceutical company Novartis in connection with an exclusive worldwide license and...

Press Releases

Hogan Lovells advises Novartis on Vedere Bio acquisition

New York, 10 November 2020 – International law firm Hogan Lovells is advising Novartis on its acquisition of Vedere Bio, a transaction which will add a powerful new platform for...

Awards and Rankings

LMG Life Sciences recognizes Hogan Lovells as Regulatory Firm of the Year for third year in a row 2020

Hogan Lovells is pleased to announce that it scored three major wins at the LMG Life Sciences eighth annual awards event, including being named Regulatory Firm of the Year for a third...

Press Releases

Hogan Lovells represents Bausch Health in acquiring option to purchase all ophthalmology assets of Allegro Ophthalmics

New York-  Hogan Lovells is representing Bausch Health Companies Inc. through its affiliate, Bausch + Lomb, its leading global eye health business, in an agreement with Allegro...

Press Releases

Hogan Lovells represents Gilead Sciences in strategic oncology collaboration with Tango Therapeutics

New York and Washington D.C., 27 August 2020 – Hogan Lovells advised Gilead Sciences, Inc. in an expanded strategic collaboration with Tango Therapeutics focused on the discovery,...

Awards and Rankings

Global law firm Hogan Lovells is pleased to announce the firm has been shortlisted in 11 categories for the eighth Annual LMG Life Sciences Americas Awards 2020

The LMG Life Sciences Awards highlight the firms, individuals, and companies behind the most innovative and challenging Life Sciences legal work of the past year, as well as those driving...

Press Releases

Hogan Lovells team advises Gilead Sciences in a license agreement with Xencor, Inc. for Use of XmAb® Antibody Technologies in investigational agents for HIV

New York, 14 January 2020 – International law firm Hogan Lovells has advised Gilead Sciences, Inc. in entering into a technology license agreement with Xencor, Inc., a clinical-stage...

Press Releases

Hogan Lovells advised Altavant Sciences in its acquisition of Onspira Therapeutics

New York, 8 January 2020 – International law firm Hogan Lovells advised clinical-stage biopharmaceutical company Altavant Sciences in its acquisition of Onspira Therapeutics, a...

Loading data